Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Some extracts from the Cohen Report

Well my figures are just taking the rev's we would need with an estimated net diividing that by ourauthorized shares and then giving that number a 15 PE...nothing more than that...simplistic really.

The investment world wants $$$$ reptitive ones and the more scruntiny they put on stocks today the more we'd need those type of numbers to get to $5/share...Rg sees it that way too...the BB just isn't the place to be...we'll get our PPs movement with a good reexam result it just wont be anywhere near $5/share and we need that to getoff the BB.

Very few CEO's/BOD's would announce such plans up front and be so oopen about it....most wait till the last minute and use it aa a lifeline to keep from getting delisted..in our case it's a matter of moving forward with some revenue and some promising acqusitions to get us to a decent exchange with less OS so when the demand hits there is less available to buy...if we have something great happen and rev's blast off...great...play it out as long as we can to get the highest PPS we can...if the market holds us to a buck or a little more a share..then go for it and make the RS when things are looking good and put this BB exchange far far behind us...you andmawny othersw may not like a RS...i don't particularly like them either ...but for the right reason not only am I for it...IMO it's a sure thing to happen.

Share
New Message
Please login to post a reply